Tab Application Banner
  • Users Online: 460
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2009  |  Volume : 4  |  Issue : 3  |  Page : 89-93

Correlation of time to institution of disease modifying antirheumatic drugs with radiological outcome in rheumatoid arthritis


1 Department of Rheumatology, Fortis Flt Lt Rajan Dhall Hospital, New Delhi, India
2 Clinical Immunology and Rheumatology Service, Department of Medicine, New Delhi, India
3 Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India

Correspondence Address:
Ashok Kumar
Department of Rheumatology, Fortis Flt Lt Rajan Dhall Hospital, New Delhi
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Background: Disease modifying antirheumatic drug (DMARD) therapy is believed to retard the radiological pro- gression of disease in rheumatoid arthritis (RA) patients. Sooner the treatment is introduced, better is the expected outcome. This concept was formally tested in this retrospective study by analyzing the relationship between time to institution of DMARDs in the first 5 years of RA and its radiological outcome. Methods: Two hundred adults with RA of more than 5 years duration taking DMARDs for at least 1 year were recruited in the study. Work up included detailed clinical evaluation, X-rays of both hands and feet AP view, assess- ment of rheumatoid factor (RF) titres, and calculation of van der Heijde-modified Sharp score, HAQ-DI and deformity score. Radiological score was correlated with the time to institution of DMARDs. Results: The mean age of study patients was 43.7 years and 92% were women. Median duration of disease was 7 years (IQR 5, 10) and 83% were RF positive. Time lag before starting DMARDs was divided into < 3 months, 3-12 months, 1-3 years and 3-5 years and the number of patients in these subgroups was 16, 86, 63 and 35 respectively. The corresponding median radiological scores were 5 (IQR 0, 30), 9.5 (IQR 0, 27), 22 (IQR 16, 36) and 36 (IQR 26, 56) respectively. There was a significant rise in radiological score with increasing time lag but the difference between < 3 months and 3-12 months categories was not statistically significant. Radiological score correlated significantly with RA articular damage index, HAQ score and total duration of RA but it did correlate with RF positivity. Conclusion: Crucial therapeutic window in RA appears to be the first year, after which the radiological score tends to rise sharply.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed483    
    Printed12    
    Emailed0    
    PDF Downloaded63    
    Comments [Add]    

Recommend this journal